This is a summary of the European public assessment report (EPAR) for Clopidogrel Krka d.d. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Clopidogrel Krka d.d.
Therapeutic Indication
N/A
Therapeutic Area (MeSH)
ATC Code
B01AC03
ATC Item
N/A
Pharmacotherapeutic Group
N/A
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| clopidogrel (as hydrochloride) | N/A | clopidogrel (as hydrochloride) |
EMA Name
Clopidogrel Krka d.d. (previously Zopya)
Medicine Name
Clopidogrel Krka d.d. (previously Zopya)
Aliases
N/ANo risk management plan link.
